KCSA
Public Relations
WORLDWIDE NEWS
--------------------------------------------------------------------------------
Public & Investor Relations, Corporate & Marketing Communications
FOR: SAFESCIENCE, INC.
COMPANY CONTACT: MEDIA CONTACT:
Rick Pierce, V.P., Finance & Investor Relations Douglas MacDougall
SafeScience, Inc. Feinstein Kean Healthcare
(617) 422-0674 (617) 577-8110
www.safescience.com www.fkhealth.com
------------------- ----------------
IR CONTACT:
Paul Holm / Bonnie Stretch
KCSA Public Relations Worldwide
(212) 896-1201 / (212)896-1206
[email protected]/[email protected]
--------------------------------
www.kcsa.com
------------
FOR IMMEDIATE RELEASE
---------------------
FORMER CHAIRMAN AND CEO OF SAFESCIENCE AGREES
NOT TO SELL STOCK FOR TWO YEARS
BOSTON, MA-JUNE 5, 2000 - SafeScience Inc. (NASDAQ: SAFS) is pleased to announce
that it has reached an amicable understanding with Dr. Platt, its former
Chairman and CEO. He has agreed to not sell his stock until June 29, 2002 except
as part of an underwritten public offering of the Company's common stock for
which he has been granted registration rights. Dr. Platt will continue to
cooperate in relation to all intellectual property licensed from him under
agreements exclusive to SafeScience. The Company is grateful to Dr. Platt for
his contributions.
SAFESCIENCE
SafeScience is developing and in-licensing a portfolio of efficacious
pharmaceutical, agricultural, and consumer products to be marketed under the
SafeScience(R) world brand, as an alternative to conventional products employing
potentially harmful chemicals. The Company's human therapeutic products include
GBC-590, a unique compound to treat cancer, which is in human clinical trials,
as well as a promising new antifungal compound, CAN-296, for the treatment of
human fungal infections, currently in pre-clinical testing. In the area of
agriculture,
(more)
<PAGE>
SafeScience is introducing Elexa(R) Plant Defense Booster, an innovative
approach, which stimulates the plant to protect itself against pathogens.
SafeScience's line of consumer and industrial products include environmentally
and human-safe cleaners, which are being marketed through both retail and
commercial channels. Further information is available on SafeScience's web site:
http://www.safescience.com.
--------------------------
# # #
Safe Harbor Statement
Any statements contained in this release that relate to future plans, events or
performance are forward-looking statements that involve risks and uncertainties,
including, but not limited to, risks of product nonapproval or product
development and market acceptance risks, the impact of competitive products and
pricing, the results of current and future licensing and other collaborative
relationships, the results of financing efforts, developments regarding
intellectual property rights and litigation, and other risks identified in the
Company's Securities and Exchange Commission filings. Actual results, events or
performance may differ materially. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as the date
hereof. The Company undertakes no obligation to publicly release the results of
any revisions to these forward-looking statements that may be made to reflect
events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events.
This press release and prior releases are available on the KCSA Public Relations
Worldwide Web site at www.kcsa.com.
------------
